NCT01207973View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetics and -Dynamics of Multiple Rising Oral Doses of BI 113823 in Patients Patients With Osteoarthritis of the Knee

PHASE1TerminatedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

January 31, 2011

Conditions
Osteoarthritis
Interventions
DRUG

BI 113823

5 dose-groups of multiple oral doses of BI 113823

Trial Locations (1)

Unknown

1272.2.1 Boehringer Ingelheim Investigational Site, München

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY